A new report commissioned by LogiPharma revealed the growing impact of artificial intelligence (AI) and machine learning (ML) on pharmaceutical supply chains, highlighting AI’s shift from a “nice-to-have” to a “need-to-have.”
A new report commissioned by LogiPharma revealed the growing impact of artificial intelligence (AI) and machine learning (ML) on pharmaceutical supply chains, highlighting AI’s shift from a “nice-to-have” to a “need-to-have.”
“AI is no longer just a tool for efficiency; it’s becoming a core enabler for pharmaceutical companies striving to meet the demands of a complex, fast-evolving market,” says Will Robinson, conference director of LogiPharma.
Comments are closed